Casado LF, Hernández JA, Jarque I, Echave M, Casado MA, Castro A Cost-utility of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia 20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017 POSTER